Kate Broderick

Chief Scientific and Innovation Officer Artis BioSolutions

Seminars

Wednesday 22nd July 2026
From DNA to RNA/LNP in Days: Accelerating mRNA Development with Rapid Synthetic DNA Manufacturing
12:10 pm
  • Rapid, High-Quality IVT Templates: Cell-free synthetic DNA with fast turnaround, competitive pricing, and precise Poly(A) tail control to accelerate mRNA development
  • An Integrated Development Workflow: From synthetic DNA to RNA and RNA/LNP manufacturing, enabling faster personalized therapies and agile pandemic response
Kate Broderick (1)